The New Jersey Department of Health confirmed that it has recorded its first pediatric flu death of the 2025-2026 season. The ...
Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...
SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations -- Dosing of the first participant in the Phase 1b ...
On track to report interim results from approximately 25 six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 2026Received ...
The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.
Bristol-Myers Squibb Company (NYSE: BMY) is one of the cheap stocks to buy for the next 3 years. On January 9, Scotiabank ...
Arcturus Therapeutics (NASDAQ:ARCT) CEO and President Joe Payne outlined the company’s current focus on messenger RNA (mRNA) therapeutics, emphasizing a leaner operating profile and a near-term set of ...
Daily Voice on MSN
NJ 2-year-old dies of flu complications, NJ reports first pediatric death of season
A North Jersey family is mourning the loss of a 2-year-old boy who they say died of flu-related complications. Isaias ...
There are no FDA-approved therapies for the treatment of OI.
The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...
Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback